close

Kilitch Drugs (India) Ltd

Know More
NSEBSE

249.050.00 (0.00%)

12:00 AM,22nd Sep 2023

248.00-2.00 (-0.80%)

04:01 PM,27th Sep 2023

BSE : 524500

NSE : KILITCH

Sector : Health care

ISIN Code : INE729D01010

  • NSE
  • BSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: Sep 27 2023 | 04:01 PM IST

Market Cap (₹ Cr)

400

Turnover (₹ Cr)

0.12

Volume (Shares)

48461

Face Value

10

52-WK High

250.00

52-WK High Date

26 Sep 2023

52-WK Low

125.00

52-WK Low Date

14 Mar 2023

All Time High

275.10

All Time High Date

04 Jan 2022

All Time Low

17.00

All Time Low Date

13 Jun 2013

Kilitch Drugs (India) Ltd

Kilitch Drugs (India) Limited (KDIL) was incorporated in May 1992 as a public limited company. The Company is a pharmaceutical company engaged in development manufacturing and marketing of quality finished dosages. The Company is one of the most reliable manufacturer of injectables in India and one of the largest manufacturer of cephalosporins in Africa having its manufacturing unit located in India and Ethiopia. Its services range from manufacturing to marketing a host of formulations in all dosage forms i.e. solid liquid and parenteral forms of creating safe pharmaceutical solutions.The Company went public in Feb.'94 to set up a pharmaceutical formulation plant at Thane to manufacture pharmaceutical products in the form of tablets capsulesliquid orals ointments creams and injectables. Even before the plant was commissioned the company came out with a rights issue in Oct.'95 to expand the injectible capacity. Commercial production at the plant at Thane commenced in 1996. The company has two divisions - O T C and ethical.A Pharmaceutical formulation plant at Sana'a Republic of Yemen was set up at a cost of Rs 15 crore by entering into an agreement with Al-Fath Trading Corporation.It also entered into an agreement with a Miami company for the export of their medicine to West Indies south and central America.The company entered into a contract with one of the leading company in the Republic of Yemen which it had set up at a cost of Rs 2.5-cr tanning unit which was implemented in the year 1995-96. The company had set up a bulk drug unit at Patalganga Maharashtra for producing raw materials for formulations. The company exports to Sudan Yemen middle-east Miami and certain south American companies. KDIL started marketing a range of injectables from the factory on ethical basis. The company also introduced a new product clue-plus Bon-Bon Gripe Water and Kilitch Balm.The Company launched a new product 'BENIN' in the market in 2011. During the year 2011-12 the Company sold its business located at Paonta Sahib Himachal Pradesh as a going concern on a slump sale basis along with transfer of services set forth in the Business Transfer Agreement (BTA). The undertaking was sold and transferred on 28th February 2012 after getting all the necessary clearances as indicated in the BTA. It retained its Name Trademark (Kilitch) and all other properties and assets at Mumbai. It transferred certain products by entering into a Product Transfer Agreement (PTA) with Akorn India Pvt. Ltd. (AIPL) by which the right to manufacture certain products by the Company at Mumbai were sold to AIPL.

Kilitch Drugs (India) Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

400

EPS - TTM (₹) [S]

10.50

P/E Ratio (X) [S]

2.00

Face Value (₹) 10
Latest Dividend (%)5.00
Latest Dividend Date 20 Sep 2019
Dividend Yield (%) -
Book Value Share (₹) [S]124.23
P/B Ratio (₹) [S]2.00
[*C] Consolidated [*S] Standalone

Funds Owing this Stock

Scheme Name Amount Invested ( ₹ Cr ) No Of Shares Net Asset (%)

Research Reports

Date BrokerActionPrices(Rs)Report
Data Not Found

Stock Strength

Today's Low/High

240.00

249.10

Week Low/High

223.55

250.00

Month Low/High

183.00

250.00

Year Low/High

125.00

250.00

All time Low/High

0.75

275.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week10.62%10.15%-2.19-0.93%
1 Month33.11%32.19%1.902.34%
3 Month27.20%29.51%5.004.78%
6 Month63.53%70.70%14.9316.08%
1 Year49.80%49.80%15.7015.93%
3 Year201.51%202.43%76.8478.43%

Financials

Graph
Table

Bulk/ Block

ALL
NSE
BSE
ALL
BUY
SELL
DateClient NameExchangeTransactionQuantityPrice
06-03-2018BP FINTRADE PRIVATE LIMITEDNSESELL5681198.98
06-03-2018BP FINTRADE PRIVATE LIMITEDNSEBUY7821496.36
06-03-2018SHAH DIPAK KANAYALALNSESELL6669996.35
01-03-2018SHAH DIPAK KANAYALALNSESELL80000115.88
27-02-2018RONAK BANSALNSEBUY72184122.90
27-02-2018RONAK BANSALNSESELL72184131.28
22-01-2018ANKUR TUKARAM MAYEKARBSESELL15020085.39
22-01-2018ANKUR TUKARAM MAYEKARBSEBUY15020085.23
22-01-2018ARUNA DINESH SHAHBSEBUY15040089.32
22-01-2018ARUNA DINESH SHAHBSESELL15040085.23

Load More

Peer Group Comparison

NamePrice(In Rs)Chg(%)Mkt Cap(Rs Cr)Sales(Rs Cr)Profit(Rs Cr)EPS(Rs)P/E(x)

Shareholding Pattern

Jun 2023
Archive
CategoryShare(%)
Promoter68.25
Financial Institutions Banks0.00
Foreign Institutional Investors0.00
Insurance Companies0.00
Mutual Funds Uti0.00
Other Institutional Investors0.00
Indian Public27.40
Others Non Institutional Investors4.35
Custodians0.00

Corporate Action

Announcement DatePurposeFromToRemarks
Data Not Found

Price History

Search for Price History

DateOpenHighLowCloseSharesTrades
Data Not Found

Load more

Company Info

Company Information

Managing Director : Mukund P Mehta

Whole-time Director : Bhavin M Mehta

Independent Director : Hemang Engineer

Whole-time Director : Mira Bhavin Mehta

Independent Director : Murti Vasudev Krishna

Independent Director : Venkita Subramanian Rajan

Company Sec. & Compli. Officer : Pushpa Nyoupane

Registered Office: C-301/2 MIDC TTC Indl Area, Pawane Village,Thane,Maharashtra-400705 Ph: 91-022-27670322/27680913/65144185

Email:info@kilitch.com

URL:http://www.kilitch.in